Correction of iron deficiency and iron deficiency anemia in women of reproductive age: choice of a drug within framework of concept of patient blood management

The article presents a review of the literature and our own data on the problem of prevention, diagnosis and treatment of iron deficiency and iron deficiency anemia in patients of reproductive age with a burdened somatic status with the development of a chronic inflammatory process. In the concept of patient blood management (PBM), the diagnosis and treatment of anemia in patients with gynecological diseases requiring subsequent surgical treatment is given paramount importance, since anemia and iron deficiency are considered risk factors for worse treatment outcomes for patients. Women with gynecological pathology often have diseases that are accompanied by the development of a systemic inflammatory response, which leads to activation of hepcidin protein synthesis and the development of so-called anemia of inflammatory diseases. Data are presented indicating the effectiveness and safety of the sucrosomial iron drug (SiderAL® Forte) in obstetric and gynecological patients with increased levels of C-reactive protein in combination with iron deficiency and iron deficiency anemia. The increase in ferrokinetic parameters in patients receiving sucrosomial iron is due to the unique physicochemical and pharmacokinetic characteristics of sucrosome, which provides protection of sucrosomial iron from the effects of gastric juice, excluding contact with the mucous membrane of the gastrointestinal tract and its absorption through special M-cells of the small intestinal mucosa followed by the release of iron in liver cells. Sucrosomial iron is novel, convenient, effective, and well tolerated compared with traditional oral iron supplements.

1. Shander A, Hardy J-F, Ozawa S, Farmer SL, Hofmann A, Frank SM, et al. A global definition of Patient Blood Management. Anesth Analg. 2022; 135: 476–488. DOI: 10.1213/ANE.0000000000005873

2. Isbister J, Pearce BL, Delaforce AS, et al. Patients’ choice, consent, and ethics in patient blood management. Anesth Analg. 2022; 135: 489–500 WHO. Available at: https://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf. Accessed: February 2022

3. Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, et al. Multimodal Patient Blood Management Program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg. 2019; 269: 794–804. DOI: 10.1097/SLA.0000000000003095

4. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The Important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016; 264 (1): 41–46. DOI: 10.1097/SLA.0000000000001646

5. Gupta PKMD, Sundaram AMMPH, MacTaggart JNMD, et al. Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg 2013; 258: 1096–1102

6. Kloka JA, Friedrichson B, Jasny T, Old O, Piekarski F, Zacharowski K, Neef V. Anemia, red blood cell transfusion and administration of blood products in obstetrics: a nationwide analysis of more than 6 million cases from 2011–2020. Blood Transfus. 2024; 22: 37–45. DOI: 10.2450/BloodTransfus.528

7. Browning RM, Trentino K, Nathan EA, et al. Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion. Aust N Z J Obstet Gynaecol 2012; 52: 455–459.

8. Munro M. G. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 3–22. DOI: 10.1016/j.bpobgyn.2016.09.011

9. Stuklov N. I., Kozinets G. I., Levakov S. A., Ogurtsov P. P. Anemia in gynecological and oncogynecological diseases. M.: MIA; 2013. (In Russ.).

10. Stuklov N. I. Iron deficiency anemia in the practice of a gynecologist. Algorithms for diagnosis, prevention and treatment. Obstetrics and gynecology. 2016; 7: 99–104 (In Russ.). http://dx.doi.org/10.18565/aig.2016.7.99–104

11. Smirnov O. A. Iron is a liver regulatory hormone hepcidin and its place in the innate immune system. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2010; 5: 10–4. (In Russ.).

12. Levina A. A., Kazyukova T. V., Tsvetaeva N. V. Hepcidin as a regulator of iron hemostasis. Pediatrics. 2008; 87 (1): 67–74. (In Russ.).

13. Benotti PN, Wood GC, Kaberi-Otarod J, Still CD, Gerhard GS, Bistrian BR. New concepts in the diagnosis and management approach to iron deficiency in candidates for metabolic surgery: should we change our practice? Surg Obes Relat Dis. (2020) 16: 2074–81. DOI: 10.1016/j.soard.2020.08.018

14. Purdy JC, Shatzel JJ. The hematologic consequences of obesity. Eur J Haematol. (2021) 106: 306–19. DOI: 10.1111/ejh.13560

15. Pavlova V. Yu., Smolkov M. A. Anemia of chronic diseases. Attending doctor. 2021; 3 (24): 51–55. (In Russ.). DOI: 10.51793/OS.2021.24.3.010

16. Tsvetaeva N. V., Levina A. A., Mamukova Yu. I. Fundamentals of regulation of iron metabolism Clinical oncohematology. 2010; (3): 278–283. (In Russ.).

17. Asperti M, Gryzik M, Brilli E, Castagna A, Corbella M, Gottardo R, Girelli D, Tarantino G, Arosio P, Poli M. Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation. Nutrients. 2018 Sep 21; 10 (10): 1349. DOI: 10.3390/nu10101349

18. Cappellini M. D., Comin-Colet J., de Francisco A., Dignass A., Doehner W., Lam C. S., Macdougall I. C., Rogler G., Camaschella C., Kadir R. et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am. J. Hematol. 2017; 92: 1068–1078. DOI: 10.1002/ajh.248207

19. Mironova O. Yu., Panferov A. S. Anemia of chronic diseases: current state of the problem and prospects. Therapeutic archive. 2022; 94 (12): 1349–1354. (In Russ.). DOI: 10.26442/00403660.2022.12.201984

20. Fletcher A, Forbes A, Svenson N. et al. Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children. Br. J. Haematol. 2021; 196 (3): 523–9. DOI: 10.1111/bjh.17900

21. De Franceschi L., Iolascon A., Taher A., Cappellini M. D. Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment. Eur. J. Intern. Med. 2017; 42: 16–23. DOI: 10.1016/j.ejim.2017.04.018

22. Gorokhova S. G., Ryazhenov V. V., Emchenko I. V. Pharmacoeconomic assessment of the effectiveness of iron supplements in the correction of anemia during the preparation of patients for major planned surgical interventions. Clinical pharmacology and therapy. 2013; 22 (3): 47–52. (In Russ.).

23. Stuklov N. I., Semenova E. N. Treatment of iron deficiency anemia. What is more important, effectiveness or tolerability? Is there an optimal solution? Journal of International Medicine. 2013; 1 (2): 47–55. (In Russ.).

24. Gómez-Ramírez S., Brilli E., Tarantino G., Muñoz M. Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation. Pharmaceuticals. 2018; 11: 97. DOI: 10.3390/ph11040097

25. Vyalov S. S. Iron deficiency conditions: clinical picture, diagnosis and treatment options. Clinical pharmacology and therapy. 2015; 24 (4): 74–80. (In Russ.).

26. Brilli E., Lipiński P., Barnadas R. et al. Sucrosomial Iron Absorption Involve M Cells Interaction. Blood. 2017; 130: 2217–2217. DOI: 10.1182/BLOOD.V130.SUPPL_1.2217.2217

27. Yu, P.P., Chang, Y.Z. and Yu, P. (2015) Iron Liposome: A More Effective Iron Supplement for Sports Anemia and Anemia of Inflammation. Journal of Pharmaceutical Care & Health Systems. 84: 1–3. https://doi.org/10.4172/2376–0419.S4–002

28. Tarantino G., Brilli E., Zambito Y. et al. Sucrosomial® iron: A new highly bioavailable oral iron supplement. Blood. 2015; 126: 4561–4562. DOI:10.1182/Blood.V126.23.4561.4561

29. Brilli E., Romano A., Fabiano A. et al. Sucrosomial® technology is able to promote ferric iron absorption: Pre-clinical and clinical evidences. Blood. 2016; 128: 3618. DOI: 10.1182/BLOOD.V128.22.3618.3618

30. Giordano G. Reduction of inflammatory markers with liposomal iron (Sideral®). Pre-clinical and clinical results. Exp. Rev. Hematol. 2016; 9 (Suppl. S 1): S 17. DOI: 10.1080/17474086.2016.1217153

31. Stuklov N. I. Iron deficiency syndromes associated with diseases of the gastrointestinal tract: state-of-the-art and new prospects for treatment. Кlin. med. 2016; 94 (6): 410–418. (In Russ.). DOI: 10.18821/0023‑2149‑2016‑94‑6‑410‑418

32. Gómez-Ramírez S, Brilli E, Tarantino G, Girelli D, Muñoz Manuel Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency Pharmaceuticals (Basel). 2023 Jun 6; 16 (6): 847. DOI: 10.3390/ph16060847

33. Mafodda A., Giuffrida D., Prestifilippo A., Azzarello D., Giannicola R., Mare M., Maisano R. Oral Sucrosomial® iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: A pilot study. Support. Care Cancer. 2017; 25: 2779–2786. DOI: 10.1007/s00520–017–3690-z

34. Berardi S., Foltran L., Pascoli I., Pepe A., Salmeri M. G., Busato E. Efficacy of oral Sucrosomial® iron in puerperium anemia. Exp. Rev. Hematol. 2016;9 (Suppl. S 1): 40. DOI: 10.1080/17474086.2016.1217153

35. Parisi, F., Brunetti, M., Fusè, F., Capriata, I., Mandò, C., Berti, C., et al. (2012) Relationship between Food Intake, Iron Supplementation, Haematochemical State and Outcomes in Pregnancy, in a Cohort of Pregnant Women in Italy. Woman – The Fascination of Modern Gynecology between Health and Woman Security: Upgrades and Necessities, Congress Palace, Montecatini Terme, Italy, 12–14 April 2012.

36. Dobrokhotova Yu.E., Romanovskaya V. V., Narimanova M. R. New approaches in the treatment and prevention of anemia in pregnant women. RMJ. Mother and child. 2024; 7 (1): 26–34. (In Russ.). DOI: 10.32364/2618‑8430‑2024‑7‑1‑4

37. Parisi F., Berti C., Mando C., Martinelli A., Mazzali C., Cetin I. Effects of different regimens of iron prophylaxis on maternal iron status and pregnancy outcome: A randomized control trial. J. Matern. Fetal. Neonatal. Med. 2017; 30: 1787–1792. DOI: 10.1080/14767058.2016.1224841

38. Antoine E., Mehedintu C., Mitran M., Diculescu D. Sucrosomial® iron effectiveness in recovering from mild and moderate iron-deficiency anemia in the postpartum period. BMC Pregnancy Childbirth. 2023; 23 (1): 360. DOI: 10.1186/s12884‑023‑05658‑7

39. Fedorova T. A., Borzykina O. M., Bakuridze E. M. Ivanets T. Yu., Strelnikova E. V., Tsakhilova S. Correction of iron deficiency anemia in patients with gynecological diseases using liposomal iron. Gynecology. 2017; 19 (1): 68–73. (In Russ.). URL: https://gynecology.orscience.ru/2079–5831/article/view/28629 ID: 28629

40. Kononova I. N., Dobrokhotova Yu.E., Kareva E. N., Shmakova N. A., Graban I. V., Ogurtsova T. A. Evaluation of the effectiveness of the sucrosomal form of iron in the treatment of patients with iron deficiency anemia of the 1st‑2nd degree of severity against the background of heavy menstrual bleeding. RMJ. Mother and child. 2023; 6 (4): 332–339. (In Russ.). DOI: 10.32364/2618‑8430‑2023‑6‑4‑2

41. Minushkin O. N., Ivanova O. I., Evsikov A. E. New technologies for the treatment of iron deficiency anemia. Effective pharmacotherapy. 2022; 18 (42): 64–68. (In Russ.). DOI 10.33978/2307‑3586‑2022‑18‑42‑64‑68

42. Barni S., Gascon P., Petrelli F., Garcia-Erce J.A., Pedrazzoli P., Rosti G., Giordano G., Mafodda A., Munoz M. Position paper on management of iron deficiency in adult cancer patients. Expert Rev. Hematol. 2017; 10: 685–695. DOI: 10.1080/17474086.2017.1343140

43. Ciudin A., Simo-Servat O., Balibrea J. M., Vilallonga R., Hernandez C., Simo R., Mesa J. Response to oral Sucrosomial® iron supplementation in patients undergoing bariatric surgery. The BARI-FER study. Endocrinol. Diabetes Nutr. 2018; 65: 17–20. DOI: 10.1016/j.endinu.2017.10.007

44. Singh K, Sethi Chopra D, Singh D, Singh N. Nano-formulations in treatment of iron deficiency anaemia: An overview. Clin. Nutr. ESPEN. 2022 Dec; 52: 12–19. DOI: 10.1016/j.clnesp.2022.08.032. Epub 2022 Sep 6. PMID: 36513444

45. Goobie S. M. Patient Blood Management Is a New Standard of Care to Optimize Blood Health. Anesthesia & Analgesia. 2022; 135 (3): 443–446. DOI: 10.1213/ANE.0000